Publicaciones científicas

An imbalance in Akt/mTOR is involved in the apoptotic and acantholytic processes in a mouse model of pemphigus vulgaris

Maider Pretel (1), Agustín España (1), Miren Marquina (1), Beatriz Pelacho (2), Jose María López-Picazo (3) and Maria J. López-Zabalza (2)
(1) Department of Dermatology, University Clinic of Navarra, School of Medicine, University of Navarra, Navarra, Spain
(2) Department of Biochemistry, University Clinic of Navarra, School of Medicine, University of Navarra, Navarra, Spain
(3) Department of Oncology, University Clinic of Navarra, School of Medicine, University of Navarra, Navarra, Spain

Revista: Experimental Dermatology

Fecha: 23/06/2009

Oncología Médica Bioquímica Clínica Dermatología

Pemphigus vulgaris (PV) is an autoimmune blistering disease characterized by the presence of IgG autoantibodies against Dsg3.

Our aim was to investigate the molecular events implicated in the development and localization of apoptosis and acantholysis in PV. We used a passive transfer mouse model together with immunohistochemical (IHC) techniques and the TUNEL assay, with quantification analysis in the basal layer of the epidermis.

The activated signalling molecules analysed and apoptotic cells detected showed an identical localization. Here in, we found for the first time in vivo an increased expression of activated HER receptor isoforms in the basal layer in PV lesions. Besides, we observed the almost total lack of activated Akt compared with a higher level of activated mTOR within the basal cells of the epidermis.

Our observations strongly support that the restriction of acantholysis to the basal layer may be due, at least in part, to the selective and increased presence of activated HER receptor isoforms in these cells. After phosphorylation of HER receptor isoforms, intracellular signalling pathways are activated in the basal layer.

In addition, the imbalance in Akt/mTOR that takes place in the basal cells may provide intracellular signals necessary for the development of apoptosis and acantholysis.

CITA DEL ARTÍCULO  Exp Dermatol. 2009 Sep;18(9):771-80

tal vezLE INTERESE

¿QUÉ TECNOLOGÍA UTILIZAMOS?

La Clínica es el hospital privado con mayor dotación tecnológica de España, todo en un único centro.

Imagen de un PET, tecnología de vanguardia en la Clínica Universidad de Navarra

NUESTROS
PROFESIONALES

Los profesionales de la Clínica realizan una labor continuada de investigación y formación, siempre en beneficio del paciente.

Imagen profesionales de la Clínica Universidad de Navarra

POR QUÉ VENIR
A LA CLÍNICA

Conozca por qué somos diferentes a otros centros sanitarios. Calidad, rapidez, comodidad y resultados.

Imagen del edificio de la Clínica Universidad de Navarra